William E. Duke
Insider Reports History
- Location
- New Haven, CT
- Signature
- /s/ Jill Andersen attorney-in-fact for William E. Duke
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by William E. Duke:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Invivyd, Inc. | Chief Financial Officer | Common Stock | 107,717 | $169,955 | $1.58 | 18 Feb 2026 | Direct |
| Invivyd, Inc. | Chief Financial Officer | Restricted Stock Units | 102,000 | $133,650 | $0.4455 | 15 Feb 2026 | Direct |
| Invivyd, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 625,000 | 29 Jan 2026 | Direct | ||
| Kaleido Biosciences, Inc. | Chief Financial Officer | Restricted Stock Units | 125,000 | 14 Jan 2022 | Direct | ||
| Apexigen, Inc. | Chief Financial Officer | Common Stock | 0 | $0.3851 | 23 Aug 2023 | Direct | |
| Apexigen, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 0 | 23 Aug 2023 | Direct |
Insider Reports Filed by William E. Duke
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IVVD | Invivyd, Inc. | 15 Feb 2026 | 4 | -$63,350 | 4 | Chief Financial Officer | 18 Feb 2026, 20:49 |
| IVVD | Invivyd, Inc. | 29 Jan 2026 | 1 | $0 | 4 | Chief Financial Officer | 30 Jan 2026, 16:20 |
| IVVD | Invivyd, Inc. | 15 Aug 2025 | 4 | -$29,808 | 4 | Chief Financial Officer | 19 Aug 2025, 21:25 |
| IVVD | Invivyd, Inc. | 15 Feb 2025 | 2 | $0 | 4 | Chief Financial Officer | 19 Feb 2025, 16:30 |
| IVVD | Invivyd, Inc. | 18 Dec 2023 | 1 | $0 | 4 | Chief Financial Officer | 20 Dec 2023, 16:40 |
| IVVD | Invivyd, Inc. | 01 Sep 2023 | 1 | $0 | 4 | Chief Financial Officer | 05 Sep 2023, 16:36 |
| IVVD | Invivyd, Inc. | 01 Sep 2023 | 0 | $0 | 3 | Chief Financial Officer | 05 Sep 2023, 16:27 |
| /report/000120919123047432-duke-william-e-2023-08-23 | Apexigen, Inc. | 23 Aug 2023 | 3 | -$10,173 | 4 | Chief Financial Officer | 25 Aug 2023, 18:42 |
| /report/000120919123039489-duke-william-e-2023-06-15 | Apexigen, Inc. | 15 Jun 2023 | 1 | -$2,212 | 4 | Chief Financial Officer | 23 Jun 2023, 17:49 |
| /report/000120919123032167-duke-william-e-2023-05-23 | Apexigen, Inc. | 23 May 2023 | 2 | -$6,904 | 4 | Chief Financial Officer | 25 May 2023, 16:21 |
| /report/000120919122061975-duke-william-e-2022-12-15 | Apexigen, Inc. | 15 Dec 2022 | 1 | -$4,773 | 4 | Chief Financial Officer | 19 Dec 2022, 16:09 |
| /report/000120919122053342-duke-william-e-2022-10-07 | Apexigen, Inc. | 07 Oct 2022 | 2 | $0 | 4 | Chief Financial Officer | 11 Oct 2022, 16:50 |
| /report/000120919122044827-duke-william-e-2022-07-29 | Apexigen, Inc. | 29 Jul 2022 | 0 | $0 | 3 | Chief Financial Officer | 08 Aug 2022, 16:52 |
| /report/000120919122003528-duke-william-e-2022-01-14 | Kaleido Biosciences, Inc. | 14 Jan 2022 | 2 | $0 | 4 | Chief Financial Officer | 18 Jan 2022, 16:11 |
| /report/000120919121054430-duke-william-e-2021-09-01 | Kaleido Biosciences, Inc. | 01 Sep 2021 | 1 | $0 | 4 | Chief Financial Officer | 02 Sep 2021, 16:16 |